Metagenomi, Inc. Common Stock (MGX) Stock Analysis & Investment Frameworks
Metagenomi, Inc. Common Stock (MGX) stock analysis on Invetso. Review Metagenomi, Inc. Common Stock’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Metagenomi, Inc. Common Stock Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Metagenomi, Inc. Common Stock Key Financial Metrics
- Market Cap: $28.71M
- Revenue: $25.21M
- ROE: -63.65%
- ROIC: -65.88%
- Dividend Yield: N/A
About Metagenomi, Inc. Common Stock
Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.
Metagenomi, Inc. Common Stock Investment Frameworks
Invetso analyzes Metagenomi, Inc. Common Stock (MGX) across the following frameworks:
- Metagenomi, Inc. Common Stock 10Y Growth Potential
- Metagenomi, Inc. Common Stock Scenario Analysis
- Metagenomi, Inc. Common Stock Risks & Opportunities
- Metagenomi, Inc. Common Stock Economic Moat
- Metagenomi, Inc. Common Stock Business Model
- Metagenomi, Inc. Common Stock Management
- Metagenomi, Inc. Common Stock SWOT Analysis
- Metagenomi, Inc. Common Stock Porter's 5 Forces
- Metagenomi, Inc. Common Stock PESTLE Analysis
- Metagenomi, Inc. Common Stock ESG Analysis